Chemotherapy in glioma

Walter Taal; Jacoline E.C. Bromberg; Martin J. van den Bent

doi:10.2217/cns.15.2

Chemotherapy in glioma

Walter Taal^*
, Jacoline E.C. Bromberg
, Martin J. van den Bent

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Review article › Academic › peer-review

80 Citations (Scopus)

30 Downloads (Pure)

Abstract

The treatment of glial brain tumors begins with surgery, and standard adjuvant treatment at the end of the past millennium for high-grade glioma and high-risk low-grade glioma was radiotherapy and chemotherapy was given at recurrence. However, over the past 10 years much has changed regarding the role of chemotherapy in gliomas and it is now clear that chemotherapy has a role in the treatment of almost all newly diagnosed diffuse gliomas (WHO grade II-IV). This is the result of several prospective studies that showed survival benefit after combined chemoradiotherapy with temozolomide in glioblastoma (WHO grade IV) or after procarbazine, CCNU (lomustine) and vincristine chemotherapy in diffuse low-grade (WHO grade II) and anaplastic (WHO grade III) glioma. The current standard of treatment for diffuse gliomas is described in this overview and in addition some attention is given to targeted therapies.

Original language	English
Pages (from-to)	179-192
Number of pages	14
Journal	CNS Oncology
Volume	4
Issue number	3
DOIs	https://doi.org/10.2217/cns.15.2
Publication status	Published - 2015

Access to Document

10.2217/cns.15.2Licence: Unspecified

Chemotherapy in gliomaFinal published version, 2.23 MBLicence: Unspecified

Cite this

@article{3e9183f8d4744ff78bdad3f30279be1a,

title = "Chemotherapy in glioma",

abstract = "The treatment of glial brain tumors begins with surgery, and standard adjuvant treatment at the end of the past millennium for high-grade glioma and high-risk low-grade glioma was radiotherapy and chemotherapy was given at recurrence. However, over the past 10 years much has changed regarding the role of chemotherapy in gliomas and it is now clear that chemotherapy has a role in the treatment of almost all newly diagnosed diffuse gliomas (WHO grade II-IV). This is the result of several prospective studies that showed survival benefit after combined chemoradiotherapy with temozolomide in glioblastoma (WHO grade IV) or after procarbazine, CCNU (lomustine) and vincristine chemotherapy in diffuse low-grade (WHO grade II) and anaplastic (WHO grade III) glioma. The current standard of treatment for diffuse gliomas is described in this overview and in addition some attention is given to targeted therapies.",

author = "Walter Taal and Bromberg, \{Jacoline E.C.\} and \{van den Bent\}, \{Martin J.\}",

year = "2015",

doi = "10.2217/cns.15.2",

language = "English",

volume = "4",

pages = "179--192",

journal = "CNS Oncology",

issn = "2045-0915",

publisher = "Future Medicine Ltd.",

number = "3",

}

TY - JOUR

T1 - Chemotherapy in glioma

AU - Taal, Walter

AU - Bromberg, Jacoline E.C.

AU - van den Bent, Martin J.

PY - 2015

Y1 - 2015

N2 - The treatment of glial brain tumors begins with surgery, and standard adjuvant treatment at the end of the past millennium for high-grade glioma and high-risk low-grade glioma was radiotherapy and chemotherapy was given at recurrence. However, over the past 10 years much has changed regarding the role of chemotherapy in gliomas and it is now clear that chemotherapy has a role in the treatment of almost all newly diagnosed diffuse gliomas (WHO grade II-IV). This is the result of several prospective studies that showed survival benefit after combined chemoradiotherapy with temozolomide in glioblastoma (WHO grade IV) or after procarbazine, CCNU (lomustine) and vincristine chemotherapy in diffuse low-grade (WHO grade II) and anaplastic (WHO grade III) glioma. The current standard of treatment for diffuse gliomas is described in this overview and in addition some attention is given to targeted therapies.

AB - The treatment of glial brain tumors begins with surgery, and standard adjuvant treatment at the end of the past millennium for high-grade glioma and high-risk low-grade glioma was radiotherapy and chemotherapy was given at recurrence. However, over the past 10 years much has changed regarding the role of chemotherapy in gliomas and it is now clear that chemotherapy has a role in the treatment of almost all newly diagnosed diffuse gliomas (WHO grade II-IV). This is the result of several prospective studies that showed survival benefit after combined chemoradiotherapy with temozolomide in glioblastoma (WHO grade IV) or after procarbazine, CCNU (lomustine) and vincristine chemotherapy in diffuse low-grade (WHO grade II) and anaplastic (WHO grade III) glioma. The current standard of treatment for diffuse gliomas is described in this overview and in addition some attention is given to targeted therapies.

UR - https://www.scopus.com/pages/publications/85050579329

U2 - 10.2217/cns.15.2

DO - 10.2217/cns.15.2

M3 - Review article

C2 - 25906059

AN - SCOPUS:85050579329

SN - 2045-0915

VL - 4

SP - 179

EP - 192

JO - CNS Oncology

JF - CNS Oncology

IS - 3

ER -

Chemotherapy in glioma

Abstract

Access to Document

Other files and links

Fingerprint

Cite this